Latest Breaking News On - Kaftrio vertex pharmaceuticals - Page 1 : comparemela.com

The MHRA extended the licence for Kaftrio, a disease-modulating therapy for cystic fibrosis, to children under 12.

United kingdomNorthern irelandGreat britainAmanda pritchardAndrew wilfinJune raineDavid ramsdenNational institute for healthKaftrio vertex pharmaceuticalsCystic fibrosisVertex pharmaceuticals europeRegulatory agencyVertex pharmaceuticalsCystic fibrosis trustChanging drugMedscape united kingdom